Development of an mRNA-based therapeutic vaccine mHTV-03E2 for high-risk HPV-related malignancies.
Wang J, Wang Q, Ma L, Lv K, Han L, Chen Y, Zhou R, Zhou H, Chen H, Wang Y, Zhang T, Yi D, Liu Q, Zhang Y, Li X, Cheng T, Zhang J, Huang C, Dong Y, Zhang W, Cen S.
Wang J, et al. Among authors: lv k.
Mol Ther. 2024 May 6:S1525-0016(24)00300-9. doi: 10.1016/j.ymthe.2024.04.036. Online ahead of print.
Mol Ther. 2024.
PMID: 38715363